Conquering Malaria Joel G. Breman, MD, DTPH Fogarty International Center National Institutes of...
-
Upload
clarissa-ramsey -
Category
Documents
-
view
212 -
download
0
Transcript of Conquering Malaria Joel G. Breman, MD, DTPH Fogarty International Center National Institutes of...
Conquering Malaria
Joel G. Breman, MD, DTPH
Fogarty International Center
National Institutes of Health
Improving Population Health Workshop
Instituto Nacional de Salud Publica (INSP)
Cuernavaca, Mexico
21 – 22 June 2003
Conquering Malaria
• Burden
• Ecology and manifestations
• Successes
• Control
• Research and training
Burden
The Global Burden of Malaria
1.5 – 2.7 million deaths annually Over 1 billion clinical episodes 300 – 500 million people infected Every 10 - 30 seconds a child dies of malaria
Ecology and Manifestations
Malaria Ecology
Intrinsic and Extrinsic Factors
Controland prevention
measuresHuman
Parasite Mosquito
Social, behavioral, economic and
political factors
Environmental conditions
EXTRINSIC
INTRINSIC
Malaria’s Toll: Major Intrinsic Components
Plasmodium falciparum
Anopheles gambiae
Malaria Ecology and BurdenClinical Manifestations
Infected Mosquito
Infected Human
Chronic effects
Anemia
Neurologic/ cognitive
Developmental
Impaired growth and development
Malnutrition
Acute febrile illness
Severe illness
Hypoglycemia
Anemia
Cerebral malaria
DeathRespiratory distress
Pregnancy
Fetus
MaternalAcute illness
AnemiaImpaired productivity
Low birth weight Infantmortality
MARA/ARMA Model of Malaria Transmission, 2003
Successes
• 1899-1914, multiple demonstrations of control by reduction of Anopheline larvae and adults– 1899, Sierra Leone (antilarval); Cuba (large-
scale); Malaysia (antilarval)– 1904-1914, Panama Canal Zone; control by
larviciding, large-scale environmental modification
• 1927, elimination of A. albimanus in Barbados (first area-wide success with invading species)
Successes: Vector Control
Successes: Vector Control (2)
• 1935-1939, use of pyrethrum spraying in South Africa, Netherlands and India
• 1939-1957– 1939-1940, Elimination of A. gambiae from
Brazil and upper Nile, Egypt, 1942-1945– 1946-1957, Interruption of transmission by
anti-mosquito measures in Cyprus, Sandinia, Guyana, Venezuela and Greece; indoor residual spraying with DDT, a new major strategy
Successes: Personal Protection (3)
• 1987-2003– Multiple projects and programs using
insecticide-impregnated bed nets demonstrating overall mortality reduction and decrease in several malaria indices
Control
Vector Control
• Drainage and filling: urban*
• Chemical and biological larvicides*
• Indoor residual insecticide spraying*
• Outdoor residual insecticide spraying
*costly and effective
Personal protection (2)
• Insecticide–impregnated materials:nets, curtains, clothing*
• House screening• House location• Repellents• Fumigants
* Cost-effective for low-income countries
Antiplasmodial (3)
• Patient management: early diagnosis, treatment, referral, education
• Chemoprophylaxis• Intermittent treatment (pregnancy)*• Radical therapy for relapses (P. vivax, P.
ovale)
* cost effective
Social Action (4)
• Mobilization of individual, family, community• Health education
Management Effectiveness• Health systems: access, use, quality• Leadership: policies, strategies, tactics• Surveillance of infection and disease• Monitoring and evaluation of programs
Research and Training
Research, Training, and Support Needs Research, Training, and Support Needs According to Understanding of Diseases According to Understanding of Diseases andand
Efficacy of Control MethodsEfficacy of Control Methods
Research Needs
Efficacy of
Control Methods
High HighTraining
Some HighModerateResearch Support Needs
Low Low
Research, Training, and Support Needs Research, Training, and Support Needs According to Understanding of Diseases According to Understanding of Diseases andand
Efficacy of Control MethodsEfficacy of Control Methods
Research Needs
Efficacy of
Control Methods
High HighTraining
Some HighModerateResearch Support Needs
Low Low
SmallpoxGuinea wormPoliomyelitisH. influenzae type BMeaslesTetanus
Malaria Dengue
HIV/AIDSTuberculosis
Ebola/Marburg InfluenzaCancers
Alzheimer’s
Research Agenda• Pathogenesis
• Drug development
• Immunology and vaccine development
• Diagnostics
• Entomology
• Recent genetic breakthroughs
Conquering Malaria
For More InformationFor More Information
MIM http://mim.nih.govRBM http://www.who.intDCPP http://www.fic.nih.gov/dcpp/Joel Breman [email protected]